Also, one may wonder why warfarin used for venous thromboembolism (VTE) prophylaxis often has the same international normalized ratio of 2-3 as treatment dosing when standard enoxaparin ...

For patients with chronic kidney disease (CKD) who undergo total hip replacement (THR), the rate of major venous thromboembolism (VTE) is significantly higher in those treated with enoxaparin ...

The low–molecular-weight heparin enoxaparin is a safe and effective therapy to prevent symptomatic venous thromboembolism in patients undergoing chemotherapy for advanced pancreatic cancer ...

(HealthDay)—Once-daily enoxaparin is associated with fewer major bleeds than enoxaparin twice daily in patients with acute venous thromboembolism (VTE), according to a study published online Jan ...

SAN FRANCISCO Enoxaparin was superior to unfractionated heparin, with a 43% relative risk reduction of venous thromboembolism events, according to results from the PREVAIL study. [T]he benefits ...

Aspirin alone doesn’t seem to be enough to prevent symptomatic venous thromboembolism (VTE) in the months following total hip or knee replacement for osteoarthritis, results of the CRISTAL trial ...

Nonmajor orthopedic surgery of the lower limbs that results in transient reduced mobility places patients at risk for venous thromboembolism. Rivaroxaban may be noninferior to enoxaparin with regar ...

Implementation of a risk-based chemoprophylaxis protocol using either aspirin or low-molecular weight heparin decreased the incidence of venous thromboembolism among patients who underwent knee ...

Once-daily enoxaparin is associated with fewer major bleeds than enoxaparin twice daily in patients with acute venous thromboembolism (VTE), according to a study published online in the Journal of ...

The optimal strategy for thromboprophylaxis after major joint replacement has not been established. Low-molecular-weight heparins such as enoxaparin predominantly target factor Xa but to some exten ...

Anticoagulant efficacy to prevent VTE after hip and knee arthroplasty Fondaparinux and rivaroxaban were associated with increased risk of major bleeding in patients who underwent total hip or knee ...

The Phase II results demonstrate that TB-402 has superior antithrombotic activity to enoxaparin (Lovenox®: sanofi-aventis) with comparable safety. Enoxaparin is currently the standard treatment to ...